Cell and gene therapy continues to be on the rise, and the number of available CDMOs to support the development and manufacture of your advanced therapy also continues to rise. However, a CDMO partner with little experience in plasmid production could delay your timeline and reduce your potential to be first to market.
Ensuring that your CDMO has a safety stock of long-lead items as well as template batch records ensures a prompt start to production and increased consistency. Setting realistic and optimal expectations for communication timelines and cost proposals is also of high-importance in establishing an optimal CDMO relationship. Explore the benefits of partnering with an experienced CDMO and learn the best practices to ensure seamless plasmid production.